.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Boehringer Ingelheim
Johnson and Johnson
Chubb
Argus Health
Healthtrust
Merck
Julphar
Fuji
Express Scripts

Generated: September 20, 2017

DrugPatentWatch Database Preview

Tersera Theraps Llc Company Profile

« Back to Dashboard

What is the competitive landscape for TERSERA THERAPS LLC, and what generic alternatives to TERSERA THERAPS LLC drugs are available?

TERSERA THERAPS LLC has three approved drugs.

There are three US patents protecting TERSERA THERAPS LLC drugs.

There are forty-eight patent family members on TERSERA THERAPS LLC drugs in thirty-three countries.

Summary for Applicant: Tersera Theraps Llc

Patents:3
Tradenames:2
Ingredients:2
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996RXYesYes► Subscribe► SubscribeY ► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes► Subscribe► SubscribeY ► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996RXYesYes► Subscribe► SubscribeY ► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes► Subscribe► SubscribeY ► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996RXYesYes► Subscribe► SubscribeY ► Subscribe
Tersera Theraps Llc
ERGOMAR
ergotamine tartrate
TABLET;SUBLINGUAL087693-001Feb 24, 1983RXNoYes► Subscribe► Subscribe► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tersera Theraps Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989► Subscribe► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996► Subscribe► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996► Subscribe► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989► Subscribe► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tersera Theraps Llc Drugs

Country Document Number Estimated Expiration
Czech Republic302410► Subscribe
China1420794► Subscribe
Canada2398066► Subscribe
Slovenia1259274► Subscribe
Japan2006116339► Subscribe
Poland199979► Subscribe
China1202875► Subscribe
World Intellectual Property Organization (WIPO)0160435► Subscribe
Japan2003522609► Subscribe
Cyprus1107998► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Harvard Business School
Express Scripts
Deloitte
Daiichi Sankyo
Baxter
Farmers Insurance
McKesson
Covington
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot